← FDA Drug Approvals (Drugs@FDA)
RISPERIDONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA USA · Approved 2011-03-30
Drug application
- FDA Application #
ANDA091537- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RISPERIDONE
- Generic name
- RISPERIDONE
- Active ingredients
- RISPERIDONE
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- NATCO PHARMA USA
- Manufacturer
- Natco Pharma USA LLC
- First approval
- 2011-03-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown